Oesophageal Adenocarcinoma

Oncology·MeSH: Adenocarcinoma Of Esophagus

7 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(3)

Phase 2(3)

Drug	Company
Leucovorin	Jazz Pharmaceuticals plc (JAZZ)
mFOLFOX	Jazz Pharmaceuticals plc (JAZZ)
Ramucirumab	Jazz Pharmaceuticals plc (JAZZ)

Phase 4(1)

Drug	Company
tislelizumab	GH Research PLC (GHRS)

BioSniper tracks 7 drugs in development for Oesophageal Adenocarcinoma across 3 companies.

There are 1 clinical trial targeting Oesophageal Adenocarcinoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.